Pediatric vancomycin use in 421 hospitals in the United States, 2008

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Lasky, Tamar ^a   Greenspan, Jay ^b   Ernst, Frank R ^c   Gonzalez, Liliana ^d  

^a MIE Resources   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c Premier Research Services   (United States)

^d 3D Group for Interactive Visualization   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADOLESCENT; ARTICLE; CHILD; CHILD HOSPITALIZATION; DISEASE SEVERITY; DRUG USE; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PEDIATRIC HOSPITAL; PEDIATRICS; PRESCHOOL CHILD; PROBABILITY; RURAL AREA; SCHOOL CHILD; SKIN INFECTION; SOFT TISSUE INFECTION; UNITED STATES; URBAN AREA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; UNITED STATES; VANCOMYCIN;

EID: 84865089719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043258     Document Type: Article

References (28)

1. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, et al. (1996) Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. Jama 275: 234-240.
2. Di Pentima M, Chan S (2010) Impact of Antimicrobial Stewardship Program on Vancomycin Use in a Pediatric Teaching Hospital. Pediatr Infect Dis J.
3. Centers for Disease Control and Prevention (2002) 12-Step Program to Prevent Antimicrobial Resistance in Health Care Settings. Department of Health and Human Services.
4. Centers for Disease Control and Prevention (1995) Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Morbidity and Mortality Weekly Reports 44: 1-12.
5. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, et al. (1997) Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 18: 275-291.
6. American Academy of Pediatrics Committee on Infectious Diseases (1997) Therapy for children with invasive pneumococcal infections. Pediatrics 99: 289-299.
7. Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC Jr, Craig WA, et al. (2009) Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy 29: 1275-1279.
8. Shah SS, Sinkowitz-Cochran RL, Keyserling HL, Jarvis WR, (1999) Vancomycin use in pediatric neurosurgery patients. Am J Infect Control 27: 482-487.
9. Hopkins HA, Sinkowitz-Cochran RL, Rudin BA, Keyserling HL, Jarvis WR, (2000) Vancomycin use in pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 21: 48-50.
10. Keyserling HL, Sinkowitz-Cochran RL, Harris JM, 2nd, Levine GL, Siegel JD, et al (2003) Vancomycin use in hospitalized pediatric patients. Pediatrics 112: e104-111.
11. Bolon MK, Arnold AD, Feldman HA, Rehkopf DH, Strong EF, et al. (2005) Evaluating vancomycin use at a pediatric hospital: new approaches and insights. Infect Control Hosp Epidemiol 26: 47-55.
12. Patel SJ, Oshodi A, Prasad P, Delamora P, Larson E, et al. (2009) Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J 28: 1047-1051.
13. Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL, Levine GL, Goldmann DA, et al. (2005) Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J 24: 766-773.
14. Pakyz AL, Gurgle HE, Ibrahim OM, Oinonen MJ, Polk RE, (2009) Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers. Infect Control Hosp Epidemiol 30: 600-603.
15. (2008) Premier Perspective Database. Charlotte, North Carolina: Premier Research Services, Premier, Inc.
16. Hughes J (2008) Development of the 3 M TM All Patient Refined Diagnosis Related Groups (APR DRGs). Mortality Measurement Meeting. Cambridge, Massachusetts: Department of Health and Human Services.
17. Schabenberger O (2005) Introducing the GLIMMIX Procedure for General Linear Mixed Models. Cary, North Carolina: SAS Institute Inc.
18. Dai J, Li Z, Rocke D (2006) Hierarchical Logistic Regression Modeling with SAS GLIMMIX. Proceedings of the Thirty-first Annual SAS Users Group International Conference. Cary, North Carolina: SAS Institute Inc.
19. Li J, Alterman T, Deddens JA (2006) Analysis of Large Hierarchical Data with Multilevel Logistic Modeling Using PROC GLIMMIX. SAS Conference Proceedings: Western Users of SAS Software 2006. Irvine, California.
20. SAS Institute Inc. (2009) SAS/GRAPH 9.2: StatisticalGraphics Procedures Guide. Cary: SAS Institute Inc.
21. SAS Institute Inc. (2009) Base SAS 9.2 Procedures Guide: Statistical Procedures, Second Edition. Cary: SAS Institute Inc.
22. Kuehn BM, (2011) Antibiotic Use Tracking. Jama 306: 2661.
23. Titus A (2011) National Antibiotic Use at a Glance: How Does Your State Compare? Extending the Cure. Washington, DC: Center for Disease Dynamics, Economics & Policy.
24. Leung K-M, Elashoff RM, Rees KS, Hasan MM, Legorreta AP, (1998) Hospital- and Patient-Related Characteristics Determining Maternity Length of Stay: A Hierarchical Linear Model Approach. American Journal of Public Health 88: 377-381.
25. Wennberg JE, Fisher ES, Stukel TA, Sharp SM (2004) Use of Medicare claims data to monitor provider-specific performance among patients with severe chronic illness. Health Aff (Millwood) Suppl Web Exclusives: VAR5-18.
26. Bowman SM, Zimmerman FJ, Christakis DA, Sharar SR, Martin DP, (2005) Hospital characteristics associated with the management of pediatric splenic injuries. JAMA 294: 2611-2617.
27. Weiss PF, Klink AJ, Hexem K, Burnham JM, Leonard MB, et al. (2009) Variation in inpatient therapy and diagnostic evaluation of children with Henoch Schonlein purpura. J Pediatr 155: 812-818 e811.
28. Hersh AL, Beekmann SE, Polgreen PM, Zaoutis TE, Newland JG, (2009) Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol 30: 1211-1217.